APYX MEDICAL CORPORATION's ticker is APYX and the CUSIP is 03837C106. A total of 65 filers reported holding APYX MEDICAL CORPORATION in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,962 | -36.4% | 12,488 | 0.0% | 0.00% | – |
Q2 2023 | $62,815 | +74.7% | 12,488 | 0.0% | 0.00% | – |
Q1 2023 | $35,965 | +23.1% | 12,488 | 0.0% | 0.00% | – |
Q4 2022 | $29,222 | -48.7% | 12,488 | 0.0% | 0.00% | – |
Q3 2022 | $57,000 | -23.0% | 12,488 | 0.0% | 0.00% | – |
Q2 2022 | $74,000 | -86.4% | 12,488 | -85.0% | 0.00% | – |
Q1 2022 | $544,000 | -47.5% | 83,172 | +3.0% | 0.00% | – |
Q4 2021 | $1,036,000 | -4.7% | 80,775 | +3.0% | 0.00% | – |
Q3 2021 | $1,087,000 | +34.0% | 78,415 | -0.2% | 0.00% | – |
Q2 2021 | $811,000 | -0.2% | 78,609 | -6.6% | 0.00% | – |
Q1 2021 | $813,000 | +45.4% | 84,132 | +8.5% | 0.00% | – |
Q4 2020 | $559,000 | +52.7% | 77,532 | 0.0% | 0.00% | – |
Q3 2020 | $366,000 | -19.2% | 77,532 | -4.9% | 0.00% | – |
Q2 2020 | $453,000 | +61.2% | 81,494 | +4.2% | 0.00% | – |
Q1 2020 | $281,000 | -59.1% | 78,240 | -3.6% | 0.00% | – |
Q4 2019 | $687,000 | +30.1% | 81,185 | +4.2% | 0.00% | – |
Q3 2019 | $528,000 | +0.8% | 77,904 | 0.0% | 0.00% | – |
Q2 2019 | $524,000 | – | 77,904 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Archon Capital Management LLC | 2,238,515 | $31,003,000 | 4.38% |
Taylor Frigon Capital Management LLC | 574,199 | $7,953,000 | 2.56% |
Millrace Asset Group, Inc. | 210,869 | $2,921,000 | 1.82% |
Cowen Prime Advisors LLC | 251,759 | $3,487,000 | 1.30% |
COWEN AND COMPANY, LLC | 1,879,003 | $26,024,000 | 1.23% |
RTW INVESTMENTS, LP | 3,398,279 | $47,066,000 | 0.71% |
PURA VIDA INVESTMENTS, LLC | 857,018 | $11,870,000 | 0.36% |
WOLFF WIESE MAGANA LLC | 36,907 | $511,000 | 0.36% |
EAM Investors, LLC | 128,560 | $1,781,000 | 0.30% |
WHITE PINE CAPITAL LLC | 57,178 | $792,000 | 0.24% |